1. India’s COVID-19 vaccine update: Man joins son to take part in COVAXIN human trial at PGIMS Rohtak  Times Now
  2. Johnson & Johnson sees promising COVID-19 vaccine results after testing on monkeys  Yahoo! Voices
  3. Johnson & Johnson identifies single dose lead coronavirus vaccine, begins human trials  India TV News
  4. UK scientists immunising hundreds with experimental coronavirus vaccine  9News
  5. Johnson & Johnson starts human study of COVID-19 vaccine after promising monkey data  Reuters
  6. View Full coverage on Google News
A 54-year-old man has reportedly joined his 26-year-old son to take part in the human clinical trial of COVAXIN, India’s first indigenous coronavirus vaccine.A 54-year-old man has reportedly joined his 26-year-old son to take part in the human clinical trial of COVAXIN, India’s first indigenous coronavirus vaccine.

MOSCOW: Russia's health minister is preparing a mass vaccination campaign against the novel coronavirus for October, local news agencies reported ...MOSCOW: Russia's health minister is preparing a mass vaccination campaign against the novel coronavirus for October, local news agencies reported ...

Russia preparing mass vaccination against COVID-19 for October - CNA

MOSCOW (REUTERS) - Russia is preparing to start a mass vaccination campaign against the novel coronavirus in October, Health Minister Mikhail Murashko said on Saturday (Aug 1), RIA news agency reported.. Read more at straitstimes.com.Europe News -MOSCOW (REUTERS) - Russia is preparing to start a mass vaccination campaign against the novel coronavirus in October, Health Minister Mikhail Murashko said on Saturday (Aug 1), RIA news

Russia plans mass vaccination against coronavirus from October, Europe News & Top Stories - The Straits Times

Russia's first potential COVID-19 vaccine will win local regulatory approval in the first half of August and be administered to frontline health workers soon afterwards, a development source close to the matter told Reuters. A state research facility in Moscow - the Gamaleya Institute - completedRussia's first potential COVID-19 vaccine will win local regulatory approval in the first half of August and be administered to frontline health workers soon afterwards, a development source close to the matter told Reuters. A state research facility in Moscow - the Gamaleya Institute - completed

Russian COVID-19 vaccine approval imminent, source says

Russias health minister is preparing a mass vaccination campaign against the novel coronavirus for October, local news agencies reported on Saturday, after a vaccine completed clinical trials.Russia's health minister is preparing a mass vaccination campaign against the novel coronavirus for October, local news agencies reported on Saturday, after a vaccine completed clinical trials.

Russia preparing mass vaccination against coronavirus for October - World - The Jakarta Post

The health minister added that another vaccine, developed by the State Research Center of Virology and Biotechnology Vector, was going through clinical trialsThe health minister added that another vaccine, developed by the State Research Center of Virology and Biotechnology Vector, was going through clinical trials

Clinical trials of Gamaleya center’s coronavirus vaccine are over - CORONAVIRUS PANDEMIC - TASS

Clinical trials of Gamaleya center’s coronavirus vaccine are over

CNN reported critics said Russia was racing ahead with its vaccine because the Kremlin wants to be seen as a global scientific leader.CNN reported critics said Russia was racing ahead with its vaccine because the Kremlin wants to be seen as a global scientific leader.

CNN: Russia races to approve vaccine within next two weeks - Business Insider

Page UnavailablePage Unavailable

Page Unavailable - ABC News

Russian scientists would release all their findings in AugustRussian scientists would release all their findings in August

All volunteers developed coronavirus immunity after Russian vaccine trials — RDIF - World - TASS

All volunteers developed coronavirus immunity after Russian vaccine trials — RDIF

The speed at which Russia is moving to roll out its first potential vaccine has sparked concerns whether Moscow prioritizes national prestige over health and safety. Russia hopes the vaccine will be launched by October.The speed at which Russia is moving to roll out its first potential vaccine has sparked concerns whether Moscow prioritizes national prestige over health and safety. Russia hopes the vaccine will be launched by October.

Russia plans coronavirus vaccination program from October | News | DW | 01.08.2020

Since COVID-19 infections have dropped dramatically in Britain, making it difficult to determine whether or not the vaccine works, Shattock said he and his colleagues are also looking to test their vaccine elsewhere.Since COVID-19 infections have dropped dramatically in Britain, making it difficult to determine whether or not the vaccine works, Shattock said he and his colleagues are also looking to test their vaccine elsewhere.

UK scientists to immunise hundreds with coronavirus vaccine | coronavirus outbreak News,The Indian Express

Russia expects to start mass anti-coronavirus vaccinations, across the country, by October, the country’s health minister has said. Mikhail Murashko added that medical workers and teachers will be given first priority.Russia expects to start mass anti-coronavirus vaccinations, across the country, by October, the country’s health minister has said. Mikhail Murashko added that medical workers and teachers will be given first priority.

Russia aims to begin public Covid-19 vaccinations in October, starting with medical workers & teachers – Minister of Health — RT Russia News

Ravinder Saini Tribune News Service Rohtak, August 1 A total of 79 volunteers have so far been successfully administered the first dose of indigenous Covid-19 vaccine, Covaxin, at Pt Bhagwat Dayal A total of 79 volunteers have so far been successfully administered the first dose of indigenous Covid-19 vaccine, Covaxin, at Pt Bhagwat Dayal Sharma Post Graduate Institute of Medical Science here under the first phase of its human clinical trial. Three volunteers were given the vaccine of Friday.

Encouraging results in first phase, 3 volunteers given second dose of Covid vaccine at Rohtak PGI : The Tribune India

Scientists at Imperial College London say they are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in a small number vaccinated so far.Scientists at Imperial College London say they are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in a small number

UK scientists develop coronavirus vaccine for immunity | Deccan Herald

A fortnight after a 26-year-old man joined the human trials of Covaxin — the country’s foremost vaccine candidate for Covid-19 — at the Post-Graduate A fortnight after a 26-year-old man joined the human trials of Covaxin — the country’s foremost vaccine candidate for Covid-19 — at the Post-Graduate

Rohtak man, 54, joins human trial of Covaxin after son | Gurgaon News - Times of India

At least 375 people will participate in the first phases of the clinical human trial of India's first COVID-19 vaccine. The second phase of the trial will be on 750 people that will be to check the vaccine’s safety and immunogenicity.At least 375 people will participate in the first phases of the clinical human trial of India's first COVID-19 vaccine. The second phase of the trial will be on 750 people that will be to check the vaccine’s safety and immunogenicity.

Human Trial Of India's Covid Vaccine 'Covaxin' Begins In Uttar Pradesh, 'Volunteers Are Fine'

The WHO has said that there is no zero risk strategy for countries that are easing international travel restrictions during the coronavirus pandemic.The updated travel advice contains minor changes from previous guidance.

COVID-19: WHO says there is no 'zero risk' for countries easing travel restrictions | Nairametrics

The development of a safe and effective vaccine will likely be required to end the COVID-19 pandemic. A group of scientists, led by Beth Israel Deaconess Medical Center immunologist Dan H. Barouch, MD, PhD, now report that a leading candidate COVID-19 vaccine developed at BIDMC in collaboration with Johnson & Johnson raised neutralizing antibodies and robustly protected non-human primates against SARS-CoV-2, the virus that causes COVID-19.The development of a safe and effective vaccine will likely be required to end the COVID-19 pandemic. A group of scientists, led by Beth Israel Deaconess Medical Center immunologist Dan H. Barouch, MD, PhD, now report that a leading candidate COVID-19 vaccine developed at BIDMC in collaboration with Johnson & Johnson raised neutralizing antibodies and robustly protected non-human primates against SARS-CoV-2, the virus that causes COVID-19.

Novel vaccine candidate robustly protects non-human primates against SARS-CoV-2

As the world is going through one of its toughest phases with the Covid-19 pandemic, world's first Corona vaccine produced by Russia is likely for publicAs the world is going through one of its toughest phases with the Covid-19 pandemic, world's first Corona vaccine produced by Russia is likely for public

World's First Corona Vaccine by August - Gulte

Moscow officials hope their vaccine will gain approval for widespread use in the next two weeksMoscow officials hope their vaccine will gain approval for widespread use in the next two weeks

Researchers 'impressed but unsurprised' over Russia's Covid-19 vaccine development - The National

The Brussels-based European Biosafety Network (EBN) has warned that the arrival of a vaccine against the coronavirus Covid-19 could be met by a Europe-wideThe Brussels-based European Biosafety Network (EBN) has warned that the arrival of a vaccine against the coronavirus Covid-19 could be met by a Europe-wide shortage of adequate syringes and needles. T

Vaccination syringes and needles – EU's next shortage?

COVID-19 vaccine trial has commenced at Uttar Pradesh's Rana Hospital and Trauma Centre.The first phase of human trial of Covaxin was completed at PGIMS RohtakCOVID-19 vaccine trial has commenced at Uttar Pradesh's Rana Hospital and Trauma Centre.The first phase of human trial of Covaxin was completed at PGIMS Rohtak

India's first COVID-19 vaccine trial starts at 8 sites; volunteers are 'fine', say doctors. Latest updates

The battle with coronavirus will not end at finding a vaccine alone. Yet another challenge will be the possibility of shortages of syringes, wipes, and protective gear needed for potential mass vaccinations against COVID-19, the European Union (EU) has warned. It has urged them to consider joint procurement, according to an EU document. The bloc […]

Possibility Of Shortage Of Syringes Once COVID-19 Vaccine Is Developed, Warns EU - ODISHA BYTES

The development of a safe and effective vaccine will likely be required to end the COVID-19 pandemic. A group of scientists, led by Beth Israel Deaconess Medical Center (BIDMC) immunologist Dan H. Barouch, ...

Single-shot COVID-19 vaccine protects non-human primates

The company aims to start a phase 3 clinical trial for Ad26.COV2-S in September.The company aims to start a phase 3 clinical trial for Ad26.COV2-S in September.

Johnson & Johnson's Coronavirus Vaccine Candidate Efficacious in Pre-Clinical Studies; Human Testing Has Begun | The Motley Fool

You have been blocked

Studies involving COVID-19 vaccine candidates in monkeys show promise of an effective vaccine, but it will take large-scale human trials to know for sure if they work. Studies involving COVID-19 vaccine candidates in monkeys show promise of an effective vaccine, but it will take large-scale human trials to know for sure if they work.

2 New But Early Studies Suggest COVID-19 Vaccine Could Be Given In 1 Dose : Coronavirus Live Updates : NPR

"coronavirus vaccines, once developed, may come without syringes and other items," the EU Commission, the bloc's executive arm, told health experts from European countries at a meeting last week."coronavirus vaccines, once developed, may come without syringes and other items," the EU Commission, the bloc's executive arm, told health experts from European countries at a meeting last week.

EU warns of risk of syringe shortages for possible coronavirus vaccine - World News

Philippine President Rodrigo Duterte said the Southeast Asian country would be given priority by China if supplies of a vaccine became availablePhilippine President Rodrigo Duterte said the Southeast Asian country would be given priority by China if supplies of a vaccine became available

Coronavirus vaccine update July 31: Covaxin trials start in UP; thousands signing up for trials in US - Moneycontrol.com

American Pharmaceutical giant, Johnson & Johnson (J&J), announced yesterday that it was starting safe human trials with its COVID-19 vaccineThe company wants to take up the question of one or two doses in its first phase of trial.

COVID-19: J&J starts vaccine trials on humans after success on monkeys | Nairametrics

Eligibility, risks, benefits and other issues to consider before volunteering.Eligibility, risks, benefits and other issues to consider before volunteering.

How to volunteer for a coronavirus vaccine trial - CNET

Scientists led by Beth Israel Deaconess Medical Center in Boston tested seven different COVID-19 vaccine candidates from J&J in nonhuman primates, landing on one that prevented the virus from infecting the animals' lungs with a single dose. The company plans to test both a one- and two-dose regimen in clinical trials.Scientists led by Beth Israel Deaconess Medical Center in Boston tested seven different COVID-19 vaccine candidates from J&J in nonhuman primates, landing on one that prevented the virus from infecting the animals' lungs with a single dose. The company plans to test both a one- and two-dose regimen in clinical trials.

J&J COVID-19 vaccine candidate protects monkeys after single dose | FierceBiotech

Russia is likely to go ahead with the approval of its COVID-19 vaccine without finishing the phase-3 human trials. Read on to know more.Russia is likely to go ahead with the approval of its COVID-19 vaccine without finishing the phase-3 human trials. Read on to know more.

COVID-19: Will Russia give the world the first vaccine against the pandemic?

Johnson & Johnson has begun human trials of its coronavirus vaccine after publishing results of its study on monkeys showing it the best vaccine candidate, offering protection from the infectious virus in one single dose.Johnson & Johnson has begun human trials of its coronavirus vaccine after publishing results of its study on monkeys showing it the best vaccine candidate, offering protection from the infectious virus in one single dose.

Johnson & Johnson identifies single dose lead coronavirus vaccine, begins human trials | Good-news News – India TV

A new single shot vaccine candidate for COVID-19 called Ad26 proven successful in protecting primates from the Sars-COV-2 infection and spread.A new single shot vaccine candidate for COVID-19 called Ad26 proven successful in protecting primates from the Sars-COV-2 infection and spread.

Single Dose of Covid-19 Vaccine Proved Successful in Pre-Clinical Study, Human Safety Trials Begin - Good News Network

SRINAGAR: A leading candidate of Covid-19 vaccine developed by global healthcare company Johnson & Johnson (J&J) raised neutralising antibodies and robustly protected monkeys against SARS-CoV-2, the virus that causes Covid-19.SRINAGAR: A leading candidate of Covid-19 vaccine developed by global healthcare company Johnson & Johnson (J&J) raised neutralising antibodies and robustly protected monkeys against SARS-CoV-2, the virus that causes Covid-19.

Johnson & Johnson COVID-19 vaccine protects monkey in single dose

The U.S. government is backing this effort with $456 million in funding.The U.S. government is backing this effort with $456 million in funding.

Monkey vaccine paves way for human trials on coronavirus - New York Daily News

A single-shot COVID-19 vaccine is being developed by scientists led by a Beth Israel Deaconess Medical Center immunologist.A single-shot COVID-19 vaccine is being developed by scientists led by a Beth Israel Deaconess Medical Center immunologist.

Single-shot COVID-19 vaccine proves successful with primates – Harvard Gazette

Access Denied

Johnson & Johnson kicked off human trials of its experimental COVID-19 vaccine Thursday, after the shots already proved successful in protecting monkeys.Johnson & Johnson kicked off human trials of its experimental COVID-19 vaccine Thursday, after the shots already proved successful in protecting monkeys, the drugmaker announced. Company honchos

Johnson & Johnson starts human vaccine trials after monkey study

Both the Russian and American COVID-19 vaccine is aiming at an August release. But what are these vaccines and how reliable are they really.Both the Russian and American COVID-19 vaccine is aiming at an August release. But what are these vaccines and how reliable are they really.

How Reliable Is This Russian & American COVID-19 Vaccine Race Aimed At August Release?

Both the Russian and American COVID-19 vaccine is aiming at an August release. But what are these vaccines and how reliable are they really.Both the Russian and American COVID-19 vaccine is aiming at an August release. But what are these vaccines and how reliable are they really.

How Reliable Is This Russian & American COVID-19 Vaccine Race Aimed At August Release?

Another coronavirus vaccine is reporting encouraging results, this time it’s the shot being developed by Johnson & Johnson.Another coronavirus vaccine is reporting encouraging results, this time it’s the shot being developed by Johnson & Johnson.

Johnson & Johnson COVID-19 vaccine effective in animal trials